Antileishmanial Activity of Myrtle Methanolic Extract against Leishmaniamajor: an In Vitro Study

  • Hossein Mahmoudvand Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
  • Hamed Salehi Lalehmarzi Bogomolets National Medical University, Kyiv, Ukraine
  • Shirzad Fallahi Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran
  • Maryam Moslehi Baharanchi Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran
  • Pardis Bayat Student Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran
  • Sareh Jahanbakhsh * Bam University of Medical Sciences, Bam, Iran
DOI: https://doi.org/10.22087/hmj.v0i0.637
Keywords: Promastigote, Amastigote, Leishmania major, Medicinal plants, Cutaneous leishmaniasis, Myrtus communis

Abstract

Background and Aim: In this study we assessed the in vitro antileishmanial activity of myrtle (Myrtus communis L.) methanolic extract against Leishmania major.Materials and Methods: The in vitro antileishmanial effects of myrtle methanolic extract against L. major promastigote and amastigotes were determined by colorimetric cell viability (MTT) assay and macrophage model, respectively. The IC50 values were also calculated by probit test in SPSS software.Results:The obtained results showed that myrtle extract was significantly inhibited promastigote growth of L. major based on a dose and time dependent manner. The measured IC50 values for myrtle methanolic extract and MA as control drug against promastigote forms of L. major were 23.6 µg/mL and 88.3 µg/mL, respectively. The obtained IC50 values were 13.8

References

World Health Organization. Control of the Leishmaniasis. Geneva: WHO (Technical Report Series 949). 2010;5-12.

Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004;27:305-18.

Mahmoudvand H, Sharififar F, Sharifi I, Ezatpour B, Fasihi Harandi M, Makki MS, Sareh Jahanbakhsh. In vitro inhibitory effect of Berberis vulgaris (Berberidaceae) and its main component, berberine against different Leishmania species. Iranian J Parasitol. 2014;9(1):28-36.

Croft SL, Sundar S, Fairlamb AH. Drug resistance in leishmaniasis. Clin Microb Rev, 2006; 19(1):11–26.

Rocha LG, Almeida JR, Macedo RO, Barbosa-Filho JM. A review of natural products with antileishmanial activity. Phytomedicine. 2005;12:514-35.

Alipour G, Dashti S, Hosseinzadeh H. Review of pharmacologi¬cal effects of Myrtus communis L. and its active constituents. Phy¬tother Res. 2014;28:1125-36.

Hosseinzadeh H, Khoshdel M, Ghorbani M. Antinociceptive, anti-inflammatory effects and acute toxicity of aqueous and eth¬anolic extracts of Myrtus communis L. aerial parts in mice. J Acu¬punct Meridian Stud. 2011;4:242-7.

Saedi Dezaki E, Mahmoudvand H, Sharififar F, Fallahi S, Monzote L, Ezatkhah F. Chemical composition along with anti-leishmanial and cytotoxic activity of Zataria multiflora. Pharm Biol. 2015;8:1-7.

Mahmoudvand H, Saedi Dezaki E, Ezatpour B, Sharifi I, Kheirandish F, Rashidipour M. In vitro and In vivo antileishmanial activities of Pistacia vera essential Oil. Planta Med. 2016;82(4):279-84.

Cowan MM. Plant products as antimicrobial agents. Clin Microb Rev. 1999;12:564-82.

Mahmoudvand H, Ezzatkhah F, Sharififar F, Sharifi I, Dezaki ES. Antileishmanial and cytotoxic effects of essential oil and methanol extract of Myrtus communis L. Korean J Parasitol. 2015;53:21–7.

Monzote L, García M, Pastor J, Gil L, Scull R, Maes L, et al. Essential oil from Chenopodium ambrosioides and main com-ponents: activity against Leishmania, their mitochondria and other microorganisms. Exp Parasitol. 2014;136:20-6.

Sokovic M, van Griensven LJLD. Antimicrobial activity of essen¬tial oils and their components against the three major patho¬gens of the cultivated button mushroom, Agaricus bisporus. Eur J Plant Pathol. 2006;116:211-24.

Abbaszadeh S, Sharifzadeh A, Shokri H, Khosravi AR, Abbasza¬deh A. Antifungal efficacy of thymol, carvacrol, eugenol and menthol as alternative agents to control the growth of food-rele¬vant fungi. J Med Mycol. 2014;24:51-6.

de Melo JO, Bitencourt TA, Fachin AL, Cruz EM, de Jesus HC, Alves PB, et al. Antidermatophytic and antileishmanial activities of essential oils from Lippia gracilis Schauer genotypes. Acta Trop. 2013;128:110-5.

Mahboubi M, Kazempour N. The antimicrobial activity of es¬sential oil from Perovskia abrotanoides Karel and its main compo¬nents. Indian J Pharm Sci. 2009;71:343-7.

Sikkema J, de Bont JA, Poolman B. Mechanisms of membrane toxicity of hydrocarbons. Microbiol Mol Biol Rev. 1995;59:201-22.

Mahmoudvand H, Ezatpour B, Jahanbakhsh S. The Antileishmanial activity of essential oils from some traditionally used medicinal plants in Iran. Herb Med J. 2016;1(1):24-8.

Kheirandish F, Delfan B, Jabari M, Ebrahimzadeh F, Rashidi M. The cytotoxic and antileishmanial effects of satureja khuzestanica essential oil. Herb Med J. 2016;1(1):11-7.

Issue
VOL 2, NO 3, 2017
Section
Original Article

Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.  Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This work is licensed under a Creative Commons license (CC-BY).  However, the license permits any user to read, copy, redistribute and and make derivative the material in any medium or format for any purpose, even commercially.